Joint Formulary & PAD

Glucarpidase - Methotrexate induced renal dysfunction

You are here : Home > Formulary Search > Glucarpidase - Methotrexate induced renal dysfunction

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Preferred

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Glucarpidase
Indication :
Methotrexate induced renal dysfunction
Group Name :
Keywords :
Carboxypeptidase, methotrexate toxicity
Brand Names Include :
Voraxaze
Important Information :

https://www.toxbase.org/ .

Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Glucarpidase is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Methotrexate induced renal dysfunction.

  • No records returned.